Cargando…
ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial
BACKGROUND: Sepsis is a major challenge in critical care and is associated with high mortality. Current management of sepsis and septic shock remains mainly supportive. Both basic and clinical research has shown that ulinastatin can improve the prognosis of sepsis. The aim of this trial is to evalua...
Autores principales: | Jiang, Wei, Yu, Xiangyou, Sun, Tongwen, Chai, Yanfen, Chang, Ping, Chen, Zhongqing, Pan, Jingye, Peng, Zhiyong, Wang, Ruilan, Wang, Xiaozhi, Xu, Yuan, Yu, Li, Zheng, Qingshan, Du, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822617/ https://www.ncbi.nlm.nih.gov/pubmed/29467017 http://dx.doi.org/10.1186/s13063-018-2513-y |
Ejemplares similares
-
The effects of Xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: An overview of systematic review and meta-analysis
por: Zhong, Guofu, et al.
Publicado: (2022) -
A retrospective study of ulinastatin for the treatment of severe sepsis
por: Meng, Chao, et al.
Publicado: (2020) -
Protective effect of rhubarb combined with ulinastatin for patients with sepsis
por: Meng, Fulei, et al.
Publicado: (2020) -
Efficacy and Safety of Xuebijing Injection Combined With Ulinastatin as Adjunctive Therapy on Sepsis: A Systematic Review and Meta-Analysis
por: Chen, Guochao, et al.
Publicado: (2018) -
Combination of Glutamine and Ulinastatin Treatments Greatly Improves Sepsis Outcomes
por: Wang, Junyan, et al.
Publicado: (2020)